An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
about
Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.Infliximab-Associated Psoriasiform Dermatitis: Case Report and Review of a Seemingly Paradoxical Inflammatory Response.Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel(®)).The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar.Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis.
P2860
An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
@en
type
label
An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
@en
prefLabel
An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
@en
P2860
P1476
An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
@en
P2093
Alan Menter
Molly Campa
P2860
P304
P356
10.1517/13543784.2015.1076793
P407
P577
2015-08-10T00:00:00Z